Home Healthcare IT Anti-VEGF Therapeutics Market Size, Share & Growth Graph by 2034

Anti-VEGF Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu, Vabysmo, Others), By Disease Type (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Myopic Choroidal Neovascularization) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRHI54734DR
Last Updated: Mar, 2026
Pages: 150
Author: Debashree Bora
Format: PDF, Excel

Market Segmentation

  1. Anti-VEGF Therapeutics Market, By Product (2022-2034)
    1. Eylea
    2. Lucentis
    3. Beovu
    4. Vabysmo
    5. Others
  2. Anti-VEGF Therapeutics Market, By Disease Type (2022-2034)
    1. Macular Edema
    2. Diabetic Retinopathy
    3. Retinal Vein Occlusion
    4. Age-related Macular Degeneration
    5. Myopic Choroidal Neovascularization
    1. North America
      1. North America Anti-VEGF Therapeutics Market, By Product
        1. Eylea
          1. Lucentis
            1. Beovu
              1. Vabysmo
                1. Others
                2. North America Anti-VEGF Therapeutics Market, By Disease Type
                  1. Macular Edema
                    1. Diabetic Retinopathy
                      1. Retinal Vein Occlusion
                        1. Age-related Macular Degeneration
                          1. Myopic Choroidal Neovascularization
                          2. U.S.
                            1. U.S. Anti-VEGF Therapeutics Market, By Product
                              1. Eylea
                                1. Lucentis
                                  1. Beovu
                                    1. Vabysmo
                                      1. Others
                                      2. U.S. Anti-VEGF Therapeutics Market, By Disease Type
                                        1. Macular Edema
                                          1. Diabetic Retinopathy
                                            1. Retinal Vein Occlusion
                                              1. Age-related Macular Degeneration
                                                1. Myopic Choroidal Neovascularization
                                              2. Canada
                                            2. Europe
                                              1. Europe Anti-VEGF Therapeutics Market, By Product
                                                1. Eylea
                                                  1. Lucentis
                                                    1. Beovu
                                                      1. Vabysmo
                                                        1. Others
                                                        2. Europe Anti-VEGF Therapeutics Market, By Disease Type
                                                          1. Macular Edema
                                                            1. Diabetic Retinopathy
                                                              1. Retinal Vein Occlusion
                                                                1. Age-related Macular Degeneration
                                                                  1. Myopic Choroidal Neovascularization
                                                                  2. U.K.
                                                                    1. U.K. Anti-VEGF Therapeutics Market, By Product
                                                                      1. Eylea
                                                                        1. Lucentis
                                                                          1. Beovu
                                                                            1. Vabysmo
                                                                              1. Others
                                                                              2. U.K. Anti-VEGF Therapeutics Market, By Disease Type
                                                                                1. Macular Edema
                                                                                  1. Diabetic Retinopathy
                                                                                    1. Retinal Vein Occlusion
                                                                                      1. Age-related Macular Degeneration
                                                                                        1. Myopic Choroidal Neovascularization
                                                                                      2. Germany
                                                                                      3. France
                                                                                      4. Spain
                                                                                      5. Italy
                                                                                      6. Russia
                                                                                      7. Nordic
                                                                                      8. Benelux
                                                                                      9. Rest of Europe
                                                                                    2. APAC
                                                                                      1. APAC Anti-VEGF Therapeutics Market, By Product
                                                                                        1. Eylea
                                                                                          1. Lucentis
                                                                                            1. Beovu
                                                                                              1. Vabysmo
                                                                                                1. Others
                                                                                                2. APAC Anti-VEGF Therapeutics Market, By Disease Type
                                                                                                  1. Macular Edema
                                                                                                    1. Diabetic Retinopathy
                                                                                                      1. Retinal Vein Occlusion
                                                                                                        1. Age-related Macular Degeneration
                                                                                                          1. Myopic Choroidal Neovascularization
                                                                                                          2. China
                                                                                                            1. China Anti-VEGF Therapeutics Market, By Product
                                                                                                              1. Eylea
                                                                                                                1. Lucentis
                                                                                                                  1. Beovu
                                                                                                                    1. Vabysmo
                                                                                                                      1. Others
                                                                                                                      2. China Anti-VEGF Therapeutics Market, By Disease Type
                                                                                                                        1. Macular Edema
                                                                                                                          1. Diabetic Retinopathy
                                                                                                                            1. Retinal Vein Occlusion
                                                                                                                              1. Age-related Macular Degeneration
                                                                                                                                1. Myopic Choroidal Neovascularization
                                                                                                                              2. Korea
                                                                                                                              3. Japan
                                                                                                                              4. India
                                                                                                                              5. Australia
                                                                                                                              6. Taiwan
                                                                                                                              7. South East Asia
                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                            2. Middle East and Africa
                                                                                                                              1. Middle East and Africa Anti-VEGF Therapeutics Market, By Product
                                                                                                                                1. Eylea
                                                                                                                                  1. Lucentis
                                                                                                                                    1. Beovu
                                                                                                                                      1. Vabysmo
                                                                                                                                        1. Others
                                                                                                                                        2. Middle East and Africa Anti-VEGF Therapeutics Market, By Disease Type
                                                                                                                                          1. Macular Edema
                                                                                                                                            1. Diabetic Retinopathy
                                                                                                                                              1. Retinal Vein Occlusion
                                                                                                                                                1. Age-related Macular Degeneration
                                                                                                                                                  1. Myopic Choroidal Neovascularization
                                                                                                                                                  2. UAE
                                                                                                                                                    1. UAE Anti-VEGF Therapeutics Market, By Product
                                                                                                                                                      1. Eylea
                                                                                                                                                        1. Lucentis
                                                                                                                                                          1. Beovu
                                                                                                                                                            1. Vabysmo
                                                                                                                                                              1. Others
                                                                                                                                                              2. UAE Anti-VEGF Therapeutics Market, By Disease Type
                                                                                                                                                                1. Macular Edema
                                                                                                                                                                  1. Diabetic Retinopathy
                                                                                                                                                                    1. Retinal Vein Occlusion
                                                                                                                                                                      1. Age-related Macular Degeneration
                                                                                                                                                                        1. Myopic Choroidal Neovascularization
                                                                                                                                                                      2. Turkey
                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                      4. South Africa
                                                                                                                                                                      5. Egypt
                                                                                                                                                                      6. Nigeria
                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                    2. LATAM
                                                                                                                                                                      1. LATAM Anti-VEGF Therapeutics Market, By Product
                                                                                                                                                                        1. Eylea
                                                                                                                                                                          1. Lucentis
                                                                                                                                                                            1. Beovu
                                                                                                                                                                              1. Vabysmo
                                                                                                                                                                                1. Others
                                                                                                                                                                                2. LATAM Anti-VEGF Therapeutics Market, By Disease Type
                                                                                                                                                                                  1. Macular Edema
                                                                                                                                                                                    1. Diabetic Retinopathy
                                                                                                                                                                                      1. Retinal Vein Occlusion
                                                                                                                                                                                        1. Age-related Macular Degeneration
                                                                                                                                                                                          1. Myopic Choroidal Neovascularization
                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                            1. Brazil Anti-VEGF Therapeutics Market, By Product
                                                                                                                                                                                              1. Eylea
                                                                                                                                                                                                1. Lucentis
                                                                                                                                                                                                  1. Beovu
                                                                                                                                                                                                    1. Vabysmo
                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                      2. Brazil Anti-VEGF Therapeutics Market, By Disease Type
                                                                                                                                                                                                        1. Macular Edema
                                                                                                                                                                                                          1. Diabetic Retinopathy
                                                                                                                                                                                                            1. Retinal Vein Occlusion
                                                                                                                                                                                                              1. Age-related Macular Degeneration
                                                                                                                                                                                                                1. Myopic Choroidal Neovascularization
                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                          Download Free Sample

                                                                                                                                                                                                          Our Clients:

                                                                                                                                                                                                          LG Electronics
                                                                                                                                                                                                          AMCAD Engineering
                                                                                                                                                                                                          KOBE STEEL LTD.
                                                                                                                                                                                                          Hindustan National Glass & Industries Limited
                                                                                                                                                                                                          Voith Group
                                                                                                                                                                                                          International Paper
                                                                                                                                                                                                          Hansol Paper
                                                                                                                                                                                                          Whirlpool Corporation
                                                                                                                                                                                                          Sony
                                                                                                                                                                                                          Samsung Electronics
                                                                                                                                                                                                          Qualcomm
                                                                                                                                                                                                          Google
                                                                                                                                                                                                          Fiserv
                                                                                                                                                                                                          Veto-Pharma
                                                                                                                                                                                                          Nippon Becton Dickinson
                                                                                                                                                                                                          Merck
                                                                                                                                                                                                          Argon Medical Devices
                                                                                                                                                                                                          Abbott
                                                                                                                                                                                                          Ajinomoto
                                                                                                                                                                                                          Denon
                                                                                                                                                                                                          Doosan
                                                                                                                                                                                                          Meiji Seika Kaisha Ltd
                                                                                                                                                                                                          LG Chemicals
                                                                                                                                                                                                          LCY chemical group
                                                                                                                                                                                                          Bayer
                                                                                                                                                                                                          Airrane
                                                                                                                                                                                                          BASF
                                                                                                                                                                                                          Toyota Industries
                                                                                                                                                                                                          Nissan Motors
                                                                                                                                                                                                          Neenah
                                                                                                                                                                                                          Mitsubishi
                                                                                                                                                                                                          Hyundai Motor Company

                                                                                                                                                                                                          We are featured on:

                                                                                                                                                                                                          WhatsApp
                                                                                                                                                                                                          Chat with us on WhatsApp